HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Intravascular use of isobutyl 2-cyanoacrylate: Part 2 Treatment of carotid-cavernous fistulas.

Abstract
The intravascular use of the rapidly polymerizing acrylic compound isobutyl 2-cyanoacrylate in four patients with carotid-cavernous fistulas is described. The monomer was injected into the cavernous sinus at craniotomy after the intraoperative angiographic identification of the fistula site and the origin of its venous drainage. All patients had postoperative angiographic documentation of fistula closure and confirmed carotid artery patency. There was no operative mortality or permanent neurological morbidity. Two patients (50%) suffered transient dysfunction in the immediate postoperative period of one of the cranial nerves that transit the cavernous sinus.
AuthorsD Samson, Q M Ditmore, C W Beyer Jr
JournalNeurosurgery (Neurosurgery) Vol. 8 Issue 1 Pg. 52-5 (Jan 1981) ISSN: 0148-396X [Print] United States
PMID7207773 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Cyanoacrylates
  • Bucrylate
Topics
  • Adult
  • Arteriovenous Fistula (diagnostic imaging, therapy)
  • Bucrylate (therapeutic use)
  • Carotid Artery Diseases (therapy)
  • Carotid Artery, Internal
  • Cavernous Sinus (diagnostic imaging)
  • Cerebral Angiography
  • Cyanoacrylates (therapeutic use)
  • Embolization, Therapeutic
  • Humans
  • Male

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: